Sfoglia per Autore
Is there a role for procalcitonin determination in avoiding unnecessary exposure to antibiotics in a non-intensive care setting?
2019 A. Giacomelli, L. van den Bogaart, M. Corbellino, L. Oreni, A. Dolci, M. Panteghini, G. Rizzardini, M. Galli, S. Antinori
Assessment of Antiepileptic Drug Concentrations in HIV-Infected versus HIV-Negative Patients: A Retrospective Analysis
2019 D. Cattaneo, S. Baldelli, A. Giacomelli, D. Minisci, P. Meraviglia, N. Astuti, M. Fusi, V. Cozzi, E. Clementi, M. Galli, C. Gervasoni
Impact of genotypic susceptibility score on cART outcomes during primary HIV infection
2019 A. Giacomelli, M. Fabbiani, I. De Benedetto, S. Nozza, E. Focà, B.M. Celesia, G. Marchetti, C. Mussini, A. Antinori, G. D'Ettorre, G. Madeddu, A. Bandera, A. Muscatello, S. Rusconi
Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study
2019 G. Baldin, A. Ciccullo, A. Capetti, S. Rusconi, G. Sterrantino, M. Cossu, A. Giacomelli, F. Lagi, A. Latini, P. Bagella, A. De Luca, S. Di Giambenedetto, G. Madeddu
Association of HIV infection with epilepsy and other comorbid conditions
2019 D. Cattaneo, A. Giacomelli, D. Minisci, N. Astuti, P. Meraviglia, C. Gervasoni
Durability of INI-containing regimens after switching from PI-containing regimens : a single-centre cohort of drug-experienced HIV-infected subjects
2019 A. Giacomelli, A. Ranzani, L. Oreni, E. Gervasi, A. Lupo, A.L. Ridolfo, M. Galli, S. Rusconi
A push for 90-90-90: Initial treatment with INSTI-based regimens against HIV-1 infection
2019 S. Rusconi, A. Giacomelli
Overlooked cases of HIV infection: An Italian tale of missed diagnostic opportunities
2019 L. van den Bogaart, A. Ranzani, L. Oreni, A. Giacomelli, M. Corbellino, S. Rusconi, M. Galli, S. Antinori, A.L. Ridolfo
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference
2019 A. Giacomelli, A. Lai, M. Franzetti, F. Maggiolo, S. Di Giambenedetto, V. Borghi, D. Francisci, G. Magnani, M. Pecorari, L. Monno, I. Vicenti, L. Lepore, F. Lombardi, S. Paolucci, S. Rusconi
Iatrogenic Cushing syndrome due to drug interaction between inhaled fluticasone and cobicistat
2019 E. Monge, V. Colombo, A. Giacomelli
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study
2019 G. Baldin, A. Ciccullo, S. Rusconi, G. Madeddu, G. Sterrantino, A. Freedman, A. Giacometti, L. Celani, A. Latini, B. Rossetti, M.V. Cossu, A. Giacomelli, F. Lagi, A. Capetti, S. Di Giambenedetto
Cohort profile : The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE)
2019 A. Ciccullo, G. Baldin, A. Capetti, V. Borghi, G. Sterrantino, A. Latini, G. Madeddu, L. Celani, F. Vignale, B. Rossetti, A. Dusina, M.V. Cossu, S. Restelli, W. Gennari, F. Lagi, A. Giacomelli, M. Colafigli, L. Brescini, A. Borghetti, C. Mussini, S. Rusconi, S. Di Giambenedetto
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS‐CoV‐2 infection: a retrospective cohort study
2020 A. Giacomelli, G. Pagani, A. Lisa Ridolfo, L. Oreni BIT, F. Conti, L. Pezzati, L. Bradanini, G. Casalini, C.R. Bassoli, V. Morena, S. Passerini, G. Rizzardini, C. Cogliati, E. Ceriani, R. Colombo, S. Rusconi, C. Gervasoni, D. Cattaneo, S. Antinori, M. Galli
Infezioni in gravidanza
2020 S. Antinori, A. Giacomelli
Trypanosoma cruzi infection in Latin American pregnant women living outside endemic countries and frequency of congenital transmission: a systematic review and meta-analysis
2020 V. Colombo, A. Giacomelli, G. Casazza, L. Galimberti, C. Bonazzetti, F. Sabaini, A.L. Ridolfo, S. Antinori
Seroprevalence of SARS-CoV-2 significantly varies with age: preliminary results from a mass population screening
2020 G. Pagani, F. Conti, A. Giacomelli, D. Bernacchia, R. Rondanin, A. Prina, V. Scolari, C.E. Gandolfi, S. Castaldi, G. Marano, C. Ottomano, P. Boracchi, E. Biganzoli, M. Galli
The crosstalk between antiretrovirals pharmacology and HIV drug resistance
2020 A. Giacomelli, L. Pezzati, S. Rusconi
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study
2020 A. Giacomelli, A.L. Ridolfo, L. Milazzo, L. Oreni, D. Bernacchia, M. Siano, C. Bonazzetti, A. Covizzi, M. Schiuma, M. Passerini, M. Piscaglia, M. Coen, G. Gubertini, G. Rizzardini, C. Cogliati, A.M. Brambilla, R. Colombo, A. Castelli, R. Rech, A. Riva, A. Torre, L. Meroni, S. Rusconi, S. Antinor, M. Galli
Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study
2020 A. Giacomelli, L. Pezzati, F. Conti, D. Bernacchia, M. Siano, L. Oreni, S. Rusconi, C. Gervasoni, A.L. Ridolfo, G. Rizzardini, S. Antinori, M. Galli
Dolutegravir plus lamivudine for hiv treatment: Does the historical genotype really matter?
2020 A. Giacomelli, F. Conti, S. Rusconi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile